Counsyl, maker of DNA tests used to diagnose predispositions to genetic diseases in prospective parents before they conceive, has brought in $2.2 million in equity, according to a filing with the SEC. Based in Redwood City, Calif., the company raised $2.7 million in 2009 from 21 undisclosed investors. The company got a write-up in The New York Times at the end of January.
VentureBeatVentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
- up-to-date information on the subjects of interest to you
- our newsletters
- gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
- networking features, and more